Ebiga-Vision Gmbh

stands for - – a science-driven approach to supporting visual health across all stages of life. Founded in 2010 and based in Greifswald, Germany, the company combines with a clear focus on : The potential of targeted micronutrition in eye care remains far from being fully realized. Our aim is to enable eye care professionals and patients to rely on the. This is why – – is at the heart of everything we do. The efficacy of ® has been demonstrated in five clinical studies, including the prospective, double-blind (). Three studies confirm the positive effect of the micronutrient composition in ® on contrast sensitivity, retinal sensitivity, visual acuity, and retinal thickness in patients with diabetes. Our (such as ®) are strictly aligned with current guidelines on micronutrient therapy, as established by the /2 studies. Our product development also incorporates recent findings from and, highlighting the benefits of - as the third macular carotenoid. To ensure scientific relevance and innovation- maintains active collaboration and exchange with the ophthalmic research and clinical community. We also contribute to knowledge transfer by hosting our own symposia at major international congresses.